Is it safe to restart mixed amphetamine salts in a patient who used them a few years ago, assuming no prior significant side effects or cardiovascular issues?

Restarting Mixed Amphetamine Salts After Prior Use

Yes, it is safe to restart mixed amphetamine salts in a patient who used them a few years ago without prior significant side effects or cardiovascular issues, provided you screen for new contraindications and monitor appropriately during reinitiation.

Key Screening Requirements Before Restarting

Before reinitiating treatment, you must evaluate for absolute contraindications that may have developed since prior use 1:

• Current MAOI use (including linezolid or IV methylene blue within 14 days) - this is an absolute contraindication 2
• Active psychotic disorder - stimulants should not be given 1
• Symptomatic cardiovascular disease - new onset heart disease, uncontrolled hypertension, or arrhythmias 1
• Glaucoma, hyperthyroidism - standard contraindications 1
• Current stimulant abuse or illicit use - unless in a controlled/supervised setting 1
• Known hypersensitivity to amphetamine products 2

Focused Cardiovascular Assessment

Obtain a targeted cardiac history looking specifically for 3:

• Decreased exercise tolerance compared to peers
• Syncope or palpitations with exercise, startle, or fright (red flags for channelopathies)
• Family history of sudden death <35 years old, unexplained drownings, motor vehicle accidents, or SIDS
• New cardiac symptoms since prior use

Perform a cardiovascular examination checking for 3:

• Pathologic murmurs (functional murmurs are not a contraindication)
• Absent or delayed femoral pulses
• Baseline blood pressure and heart rate 1

You do not need routine ECG or cardiology clearance in asymptomatic patients without cardiac history or abnormal examination 3. The risk of sudden death on stimulants (0.2-0.5 per 100,000 patient-years) is similar to the general pediatric population 3.

Reinitiation Protocol

Starting Dose Strategy

Start at the same low initial doses used for stimulant-naive patients, not at the prior maintenance dose 1:

• Begin with 5 mg of mixed amphetamine salts in the morning 1
• May require only once-daily dosing initially; add noon dose if duration insufficient 1
• Titrate upward in 5-10 mg increments weekly based on response 1

Rationale: Even though the patient tolerated the medication previously, starting low allows you to:

• Reassess current tolerance and response
• Monitor for any new adverse effects
• Optimize the minimum effective dose

Titration Schedule

Follow this structured approach 1:

Week 1: 5 mg once daily (morning)
Week 2: 10 mg daily (may split to 5 mg BID)
Week 3: 15 mg daily
Week 4: 20 mg daily

Continue titration until symptoms controlled or maximum dose reached (typically 40 mg daily for adults, though up to 60 mg may be used) 1.

Monitoring Requirements

Initial phase (first 4 weeks) 1:

• Weekly visits or phone contact
• ADHD rating scales from patient/family
• Side effect assessment at each contact
• Blood pressure and pulse at each visit

Maintenance phase 1:

• Monthly visits initially
• Blood pressure, pulse, height, weight monitoring
• Assess for tolerance, diversion risk, or new side effects

Common Pitfalls to Avoid

1. Don't restart at the old maintenance dose - Always start low and retitrate 1

2. Don't assume prior tolerance guarantees current tolerance - Medical conditions, medications, and physiology may have changed

3. Don't skip cardiovascular screening - New cardiac conditions may have developed since prior use 3, 2

4. Don't ignore psychiatric comorbidities - Screen for new-onset bipolar disorder, psychosis, or active substance use that may have emerged 2

5. Don't forget drug interactions - Review current medications, especially SSRIs, SNRIs, triptans, tramadol, or other serotonergic agents that increase serotonin syndrome risk 2

Expected Cardiovascular Effects

Long-term data shows minimal cardiovascular impact in otherwise healthy adults 4:

• Mean increase in systolic BP: 2.3 mmHg
• Mean increase in diastolic BP: 1.3 mmHg
• Mean increase in pulse: 2.1 bpm
• These changes are not clinically significant in healthy individuals

However, patients with borderline baseline values may shift to abnormal ranges, requiring closer monitoring 4.

Documentation Requirements

Document the following 1:

• Prior stimulant treatment history (medication, dose, duration, response, side effects, reason for discontinuation)
• Current indication and symptom severity
• Cardiovascular screening results
• Discussion of risks/benefits with patient
• Plan for monitoring and follow-up

The evidence strongly supports that prior successful use without adverse effects is a positive predictor for safe reinitiation, making this a straightforward clinical decision when contraindications are absent 5, 6, 7.